Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06593106 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jul 30, 2026 → Dec 30, 2026
Enrollment reduced 57% 30 → 13 participants
See other at-risk trials from Vanderbilt-Ingram Cancer Center

Record History

  1. Enrollment reduced: 30 → 13 participants Enrollment closed, study ongoing · Primary completion pushed from Jul 30, 2026 to Dec 30, 2026 · Completion pushed from Aug 31, 2026 to Aug 31, 2027 · 1 morev6 Show 4 more changesShow less
    • Enrollment closed, study ongoing
    • Primary completion pushed from Jul 30, 2026 to Dec 30, 2026
    • Completion pushed from Aug 31, 2026 to Aug 31, 2027
    • Site details revised
  2. Primary completion date: Dec 30, 2025 to Jul 30, 2026v5
  3. Start date: Oct 24, 2024 to Sep 27, 2024v4
  4. Start date changed from estimate of Nov 1, 2024 to Oct 24, 2024 Eligibility criteria expanded, about 8 wordsv3 Show 1 more changeShow less
    • Eligibility criteria expanded, about 8 words

    See this version in full on ClinicalTrials.gov ↗

  5. Trial status: Not Yet Recruiting to Recruiting Site details revisedv2 Show 1 more changeShow less
    • Site details revised
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial studies side effects and best treatment time of cryodevitalization in treating patients with early stage (stage I or stage II) lung cancer. Cryodevitalization is a type of cryosurgery that uses a flexible probe (cryoprobe) to kill tumor cells by freezing them. It is delivered at the time of standard diagnostic robotic bronchoscopy. Using cryodevitalization may be safe, tolerable and/or effective in treating patients with early stage lung cancer.
Trial Details
NCT Number NCT06593106
Lead Sponsor Vanderbilt-Ingram Cancer Center
Collaborators: National Cancer Institute (NCI), Swim Across America
Conditions Stage I Lung Cancer, Stage II Lung Cancer
Enrollment 13 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov